Intratect 5% sol perf 2.5 g/50 ml i.v., , Intratect 5% sol perf 2.5 g/50 ml i.v. flac 50 ml

7680576760060 CH-57676 J06BA02
Intratect 5% sol perf 2.5 g/50 ml i.v., , Intratect 5% sol perf 2.5 g/50 ml i.v. flac 50 ml
Intratect 5% sol perf 2.5 g/50 ml i.v., , Intratect 5% sol perf 2.5 g/50 ml i.v. flac 50 ml
Intratect 5% sol perf 2.5 g/50 ml i.v., , Intratect 5% sol perf 2.5 g/50 ml i.v. flac 50 ml
1 / 3
google

Details

Product number
5767601
CPT
-
Packaging group
-
Unit
-

Articles (1)

Intratect 5%, Infusionslösung
Infusionslösung
50
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
03/05/2025
Professional SmPC
Français
03/05/2025
Professional SmPC
Italien
03/05/2025

Detailed composition

Substance Quantity Type Category
proteina plasmatis humani
50.0 MG Substance WIZUS
immunoglobulinum humanum normale
- Substance Wirkstoff (Principe actif)
glycinum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
natrium
- Substance HBESI
acidum hydrochloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 188.25
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2007

Authorization holder

Biotest (Schweiz) AG

5102 Rupperswil

Authorization information

Swissmedic authorization number
57676
Drug name
Intratect 5%, Infusionslösung
Galenic form
LSINF
ATC Code
J06BA02
Authorization status
Z
Dispensation category
B
First authorization
15/01/2007
Authorization expiration date
31/12/9999
IT number
08.09.
Domain
Human medicine
Field of application
Immunmodulation bei idiopathischer thrombozytopenischer Purpura (ITP) Immunmodulation bei Kawasaki-Syndrom allogene Knochenmarktransplantation Substitutionstherapie bei primären Immunmangelkrankheiten Substitutionstherapie bei Myelom oder chronisch-lymphatischer Leukämie mit schwerer sekundärer Hypogammaglobulinämie und rezidivierenden Infektionen Immunmodulation bei Guillain-Barré Syndrom (GBS) Substitutionstherapie bei Kindern mit kongenitalem AIDS und rezidivierenden Infektionen

Packaging details

Description (FR)
INTRATECT 5% sol perf 2.5 g/50ml i.v. flac 50ml
Description (DE)
INTRATECT 5% Inf Lös 2.5 g/50ml i.v. Vial 50ml
Market launch
15/01/2007
Market withdrawal
01/01/2025
Narcotic (BTM)
No

Application methods

IV

Other packaging sizes

INTRATECT 5% sol perf 1 g/20ml i.v. flac 20ml
20 ML
View
INTRATECT 5% sol perf 5 g/100ml i.v. flac 100ml
100 ML
View
INTRATECT 5% sol perf 10 g/200ml i.v. flac 200ml
200 ML
View
Buy us a coffee Explore the data